GlassScriptPhysician profile
Michelle Green
NPI 1043754641
$17,648.79
in general payments reported to CMS, 2019-2025
36 companies · $12K in 2025
The $12K reported for 2025 was more than what 99% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $36.47 · 2022: $797 · 2023: $2,367 · 2024: $2,747 · 2025: $12K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,236 · Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program: $7,770 · Travel and Lodging: $760 · Long Term Medical Supply Or Device Loan: $49.95.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,235.71 |
| Compensation For Serving As Faculty Or As A Speaker For A Medical Education Program | $7,770.00 |
| Travel and Lodging | $759.58 |
| Long Term Medical Supply Or Device Loan | $49.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Dexcom, INC. | $9,449.20 | 2022-2025 | Dexcom G7 Gss (161), Dexcom Stelo Glucose Biosensor, Dexcom G6 Transmitter |
| Abbott Laboratories | $1,355.57 | 2023-2025 | Freestyle Libre 3, Freestyle Insulinx |
| Lilly USA, LLC | $1,082.19 | 2022-2025 | Jardiance, Zepbound, Mounjaro |
| Boehringer Ingelheim Pharmaceuticals, INC. | $680.68 | 2022-2025 | Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $658.60 | 2022-2025 | |
| Novo Nordisk INC | $645.91 | 2022-2025 | Rybelsus, Ozempic, Wegovy |
| Insulet Corporation | $442.60 | 2023-2025 | Omnipod |
| Medtronic, INC. | $317.48 | 2022-2025 | Simplera Sensor, Minimed 780g |
| Esperion Therapeutics, INC. | $316.37 | 2023-2025 | Nexletol, Nexlizet |
| Corcept Therapeutics | $299.26 | 2023-2024 | Korlym |
| Amgen INC. | $290.11 | 2024-2025 | Evenity, Repatha, Repatha |
| Mannkind Corporation | $263.69 | 2022-2025 | Afrezza |
| Novartis Pharmaceuticals Corporation | $237.19 | 2022-2025 | |
| Xeris Pharmaceuticals, INC. | $224.65 | 2022-2025 | Gvoke Hypopen |
| Amneal Pharmaceuticals LLC | $196.88 | 2024-2025 | Unithroid |
Show all 36 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $164.99 | 2022-2025 | |
| Pharmacosmos Therapeutics INC. | $122.79 | 2024 | Monoferric |
| Inari Medical, INC. | $104.10 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Currax Pharmaceuticals LLC | $88.02 | 2022-2024 | Contrave |
| Recordati_rare_diseases_inc. | $74.01 | 2025 | Isturisa |
| Tandem Diabetes Care, INC. | $73.41 | 2022-2024 | T:Slim X2 Insulin Pump With Control-Iq |
| Kyowa Kirin, INC. | $69.03 | 2023-2024 | Crysvita |
| Beta Bionics, INC. | $68.11 | 2025 | Ilet Bionic Pancreas, Ilet Insulin Infusion Kit Contact Detach, Ilet Insulin Infusion Kit Inset |
| Intra-Sana Laboratories | $66.02 | 2024-2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Sanofi-Aventis U.S. LLC | $61.56 | 2023-2025 | |
| Antares Pharma, INC. | $54.49 | 2023-2024 | Xyosted, Nocdurna, Tlando |
| Astrazeneca Pharmaceuticals LP | $46.30 | 2023-2024 | Farxiga |
| Biohaven Pharmaceuticals, INC. | $36.47 | 2021 | |
| Astellas Pharma US INC | $33.61 | 2023 | Veozah |
| Rhythm Pharmaceuticals, INC. | $30.81 | 2025 | Imcivree |
| Sequel Med Tech, LLC | $23.01 | 2025 | Twiist |
| Philips North America LLC | $14.92 | 2023 | |
| Ascendis Pharma Endocrinology INC | $14.68 | 2025 | Yorvipath |
| Alexion Pharmaceuticals, INC. | $14.52 | 2023 | Strensiq |
| Halozyme INC | $14.04 | 2023 | |
| Boston Scientific Corporation | $13.52 | 2024 | Watchman Flx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Green listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.